Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Shannon R Reese"'
Autor:
Natalie M Bath, Xiang Ding, Nancy A Wilson, Bret M Verhoven, Brittney A Boldt, Adarsh Sukhwal, Shannon R Reese, Sarah E Panzer, Arjang Djamali, Robert R Redfield
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211865 (2019)
Alloantibody represents a significant barrier in kidney transplant through the sensitization of patients prior to transplant through antibody mediated rejection (ABMR). APRIL BLyS are critical survival factors for mature B lymphocytes plasma cells, t
Externí odkaz:
https://doaj.org/article/029b107867da4ec9ba34a04f8fdd2243
Autor:
Richard S. Eisenstein, James A Votava, Arjang Djamali, Shannon R. Reese, Sheila A. Anderson, Kathryn M. Deck, Christopher P. Nizzi
Publikováno v:
Am J Physiol Renal Physiol
Chronic kidney disease involves disturbances in iron metabolism including anemia caused by insufficient erythropoietin (EPO) production. However, underlying mechanisms responsible for the dysregulation of cellular iron metabolism are incompletely def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fdd1b9286a21dd1bbb4617b95c810e5
https://doi.org/10.1152/ajprenal.00537.2020
https://doi.org/10.1152/ajprenal.00537.2020
Autor:
Zijian Zhang, MD, Nancy A. Wilson, PhD, Raghavan Chinnadurai, PhD, Sarah E. Panzer, MD, Robert R. Redfield, III, MD, Shannon R. Reese, MS, Jacques Galipeau, MD, Arjang Djamali, MD
Publikováno v:
Transplantation Direct, Vol 4, Iss 9, p e387 (2018)
Background. We hypothesized that immunomodulatory properties of mesenchymal stromal cells (MSC) may be considered for desensitization. Methods. Autologous or allogeneic bone marrow derived MSC were infused via tail vein at 0.5 M (0.5 × 106), 1 M, or
Externí odkaz:
https://doaj.org/article/a7033284cd544c1e97cd70df9ace142d
Autor:
Robert R. Redfield, Shannon R. Reese, Sarah E. Panzer, Yabing Huang, Kenna R. Degner, Nancy A. Wilson, Lucille Ptak, Weixiong Zhong, Ding Xiang
Publikováno v:
Transplantation
BACKGROUND Transplant glomerulopathy (TG) is a pathological feature of chronic active antibody-mediated rejection (cAMR) and is associated with renal allograft failure. The specific role of B cells in the pathogenesis of TG is unclear. METHODS We use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db2eab52644e8232055e2986829efa4
https://doi.org/10.1097/tp.0000000000003530
https://doi.org/10.1097/tp.0000000000003530
Autor:
William J. Burlingham, Bret M Verhoven, Sarah E. Panzer, Lei Shi, Robert R. Redfield, Weixiong Zhong, Xiang Ding, Shannon R. Reese, Arjang Djamali, Nancy A. Wilson, Loren C. Denlinger
Publikováno v:
Kidney360
Background: Extracellular adenosine triphosphate (ATP) binds to purinergic receptors and promotes inflammatory responses. We tested whether oxidized ATP (oATP), P2X7 receptor antagonist can attenuate acute kidney allograft rejection. Methods: Brown N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b949f1f39da915625de3636af4578f59
https://doi.org/10.34067/kid.0000692019
https://doi.org/10.34067/kid.0000692019
Autor:
Nancy A. Wilson, Kristin Van Hyfte, Neetika Garg, Fahad Aziz, Sandesh Parajuli, Shannon R. Reese, Maha Mohamed, Kenna R. Degner, Weixiong Zhong, Peter Nickerson, Arjang Djamali, Didier A. Mandelbrot, Luis G. Hidalgo, Sarah E. Panzer
Publikováno v:
Kidney International Reports
Active and chronic active antibody-mediated rejection (ABMR) are major causes of allograft loss after kidney transplantation.1 There is no standard treatment approach for ABMR, but intravenous immunoglobulin (IVIG), steroids, and targeted B-cell ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe94a5a7ad30467e7266bcdc5e31e0f
https://pubmed.ncbi.nlm.nih.gov/34013117
https://pubmed.ncbi.nlm.nih.gov/34013117
Autor:
Robert R. Redfield, Neetika Garg, Weixiong Zhong, Sandesh Parajuli, Fahad Aziz, Luis G. Hidalgo, Kenna R. Degner, Sarah E. Panzer, Maha Mohamed, Kristin Van Hyfte, Tripti Singh, Arjang Djamali, Didier A. Mandelbrot, Shannon R. Reese, Nancy A. Wilson
Publikováno v:
Kidney360
BACKGROUND: B-cell depletion is a common treatment of antibody-mediated rejection (ABMR). We sought to determine the specific immunopathologic effects of this therapeutic approach in kidney transplantation. METHODS: This was a prospective observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6152fc051a81cc1790d6f6b9acdfe987
https://europepmc.org/articles/PMC8409258/
https://europepmc.org/articles/PMC8409258/
Autor:
Sarah E. Panzer, Bret M Verhoven, Robert R. Redfield, Nancy A. Wilson, C. Dustin Rubinstein, Shannon R. Reese, Weixiong Zhong, Ding Xiang
Publikováno v:
Transplantation. 102:396-405
Background Increasingly, it is being appreciated that B cells have broad roles beyond the humoral response and are able to contribute to and regulate inflammation. The specific role of B cells in the pathogenesis of early allograft inflammation remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2120ea8b543a91a619f3790bc700d81f
https://doi.org/10.1097/tp.0000000000002010
https://doi.org/10.1097/tp.0000000000002010
Autor:
Judith Blaine, Shannon R. Reese, Sarah E. Panzer, Luis G. Hidalgo, Kenna R. Degner, James Dylewski, Megan A. O'Neill, Nancy A. Wilson
Publikováno v:
Transpl Immunol
Chronic active antibody-mediated rejection is a major cause of allograft failure in kidney transplantation. Microvascular inflammation and transplant glomerulopathy are defining pathologic features of chronic active antibody-mediated rejection and ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b12c127177db9c93009e1117536b72
https://pubmed.ncbi.nlm.nih.gov/31887408
https://pubmed.ncbi.nlm.nih.gov/31887408
Autor:
Robert R. Redfield, Xiang Ding, Sarah E. Panzer, Brittney A. Boldt, Arjang Djamali, Adarsh Sukhwal, Shannon R. Reese, Natalie M. Bath, Bret M Verhoven, Nancy A. Wilson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 2, p e0211865 (2019)
PLoS ONE, Vol 14, Iss 2, p e0211865 (2019)
Alloantibody represents a significant barrier in kidney transplant through the sensitization of patients prior to transplant through antibody mediated rejection (ABMR). APRIL BLyS are critical survival factors for mature B lymphocytes plasma cells, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74d1c87c228dae22cf8a7eb630b3dcb
http://europepmc.org/articles/PMC6368307
http://europepmc.org/articles/PMC6368307